Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 3/20 | 0.52 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | NPC1 | O15118 | 4/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.47 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.47 |
| ▸ | PTPRA | P18433 | 1/20 | 0.47 |
| ▸ | PTPRB | P23467 | 1/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13330216 | 0.89 | MAPT (0.50) | THRBMAPTNPC1L3MBTL1MAPK1 | |
| SCHEMBL29353897 | 0.86 | THRB (0.67) | THRBMAPTNPC1L3MBTL1MAPK1 | |
| SCHEMBL1394498 | 0.86 | THRB (0.67) | THRBMAPTNPC1L3MBTL1MAPK1 | |
| SCHEMBL4223162 | 0.86 | THRB (0.67) | THRBMAPTNPC1L3MBTL1MAPK1 | |
| SCHEMBL57955 | 0.86 | THRB (0.67) | THRBMAPTNPC1L3MBTL1MAPK1 | |
| SCHEMBL305524 | 0.85 | TSHR (0.57) | THRBMAPTNPC1L3MBTL1MAPK1 | |
| SCHEMBL29355385 | 0.85 | TSHR (0.57) | THRBMAPTNPC1L3MBTL1MAPK1 | |
| SCHEMBL305525 | 0.85 | TSHR (0.57) | THRBMAPTNPC1L3MBTL1MAPK1 | |
| SCHEMBL10809260 | 0.84 | THRB (0.51) | THRBMAPTNPC1L3MBTL1MAPK1 | |
| SCHEMBL5356875 | 0.84 | THRB (0.51) | THRBMAPTNPC1L3MBTL1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100108994-A1 | ELECTROLUMINESCENT METAL COMPLEXES WITH BENZOTRIAZOLES | UDC IRELAND LIMITED (IE) | 2010-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100108994-A1 | ELECTROLUMINESCENT METAL COMPLEXES WITH BENZOTRIAZOLES | OCIAD1, OCIAD2, OXA1L | THRB 2057/4885MAPT 388/4885NPC1 4461/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.